Detailed information for compound 225195

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 467.513 | Formula: C28H23F2N5
  • H donors: 1 H acceptors: 2 LogP: 6.23 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: Cc1nc(C)cc(c1)c1c(F)cc2c(c1F)n(cc/c/2=N\Nc1cnc2c(c1)cccc2)C1CC1
  • InChi: 1S/C28H23F2N5/c1-16-11-19(12-17(2)32-16)26-23(29)14-22-25(9-10-35(21-7-8-21)28(22)27(26)30)34-33-20-13-18-5-3-4-6-24(18)31-15-20/h3-6,9-15,21,33H,7-8H2,1-2H3/b34-25+
  • InChiKey: GKVZMCRVVUTSJD-YQCHCMBFSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Toxoplasma gondii Adenosine/AMP deaminase domain-containing protein 0.3408 1 1
Onchocerca volvulus Adenosine deaminase homolog 0.3408 1 1
Mycobacterium tuberculosis Probable adenosine deaminase Add (adenosine aminohydrolase) 0.3408 1 0.5
Trichomonas vaginalis adenosine deaminase, putative 0.3408 1 0.5
Trypanosoma cruzi adenosine monophosphate deaminase-like protein, putative 0.2218 0.1568 0.5
Trichomonas vaginalis adenosine deaminase, putative 0.3408 1 0.5
Trypanosoma cruzi AMP deaminase, putative 0.2218 0.1568 0.5
Trypanosoma cruzi adenosine monophosphate deaminase, putative 0.2218 0.1568 0.5
Plasmodium falciparum adenosine deaminase 0.3408 1 1
Trypanosoma brucei AMP deaminase, putative 0.2218 0.1568 0.5
Schistosoma mansoni adenosine deaminase-related 0.3408 1 1
Plasmodium vivax adenosine deaminase, putative 0.3408 1 1
Treponema pallidum adenosine deaminase 0.3408 1 0.5
Mycobacterium ulcerans adenosine deaminase 0.3408 1 0.5
Mycobacterium leprae Probable adenosine deaminase Add (ADENOSINE AMINOHYDROLASE) 0.3408 1 0.5
Loa Loa (eye worm) hypothetical protein 0.3408 1 1
Trypanosoma cruzi AMP deaminase, putative 0.2218 0.1568 0.5
Echinococcus granulosus adenosine deaminase 0.3408 1 1
Trypanosoma brucei adenosine monophosphate deaminase, putative 0.2218 0.1568 0.5
Trypanosoma cruzi AMP deaminase, putative 0.2218 0.1568 0.5
Entamoeba histolytica adenosine deaminase, putative 0.3408 1 1
Schistosoma mansoni adenosine deaminase 0.3408 1 1
Toxoplasma gondii Adenosine/AMP deaminase domain-containing protein 0.3408 1 1
Echinococcus multilocularis adenosine deaminase 0.3408 1 1
Leishmania major adenine aminohydrolase 0.3408 1 1
Trypanosoma cruzi AMP deaminase, putative 0.2218 0.1568 0.5
Loa Loa (eye worm) AMP deaminase 0.2218 0.1568 0.1568
Trypanosoma brucei AMP deaminase, putative 0.2218 0.1568 0.5
Trypanosoma brucei AMP deaminase, putative 0.2218 0.1568 0.5
Trypanosoma cruzi AMP deaminase, putative 0.2218 0.1568 0.5
Entamoeba histolytica adenosine deaminase, putative 0.3408 1 1

Activities

Activity type Activity value Assay description Source Reference
EC50 (binding) = 92 uM Inhibitory activity in a cell-free assay of DNA cleavage mediated by purified HeLa cell topoisomerase II. ChEMBL. No reference
EC50 (binding) = 92 uM Inhibitory activity in a cell-free assay of DNA cleavage mediated by purified HeLa cell topoisomerase II. ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

No external resources registered for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.